Literature DB >> 27819525

IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.

Heba Mosaad Elsayed1, Yasmin Nabiel2, Tarek Sheta3.   

Abstract

BACKGROUND: Hepatocellular carcinoma has been recorded the commonest cancer in Egypt. This increasing incidence may be attributed to the high prevalence of hepatitis C virus with its complications, so this study aimed to investigate the association between the potentially functional polymorphisms of IL12A and IL12B genes as a risk factor of development of hepatocellular carcinoma (HCC) on top of hepatitis C virus (HCV) infection in an Egyptian population.
MATERIALS AND METHODS: We genotyped two loci of IL12 which were rs568408 (3'UTR G>A) for IL12A and rs3212227 (3'UTR A>C) for IL12B in 78 patients with HCC on top of chronic HCV infection. In addition, 64 cancer-free chronic HCV patients were studied, besides 92 healthy subjects who were included as control.
RESULTS: Study of rs568408 (G>A) gene polymorphism showed that the A allele is higher while the G allele is lower in HCC cases than cancer-free chronic HCV patients (p = 0.006*). The A-containing genotypes AG and (AG+AA) were higher while the GG was lower (p = 0.009* and p = 0.005*), respectively. The study of the rs3212227 (A>C) polymorphism showed neither statistically significant differences between the C and A allele (p = 0.2) nor between CC, AC, or AC+CC in HCC cases and cancer-free chronic HCV patients (p = 0.7, p = 0.2, and p = 0.29), respectively.
CONCLUSION: Our findings showed that IL12A rs568408 (G>A) polymorphism may contribute to the risk of HCC on top of chronic HCV infection, whereas that of IL12B rs3212227 (A>C) do not.

Entities:  

Keywords:  Hepatitis C virus; hepatocellular carcinoma; interleukin-12; single-nucleotide polymorphisms

Mesh:

Substances:

Year:  2016        PMID: 27819525     DOI: 10.1080/08820139.2016.1229789

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  5 in total

1.  Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma.

Authors:  Dafeng Xu; Yu Wang; Kailun Zhou; Jincai Wu; Zhensheng Zhang; Jiachao Zhang; Zhiwei Yu; Luzheng Liu; Xiangmei Liu; Bidan Li; Jinfang Zheng
Journal:  Onco Targets Ther       Date:  2020-08-14       Impact factor: 4.147

2.  Systematic Review and Meta-Analysis on the Association between Polymorphisms in Genes of IL-12 Signaling Pathway and Hepatocellular Carcinoma Risk.

Authors:  Yao Xiao; Guodong Liu; Liansheng Gong
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

3.  Associations of IL-12, IL12R polymorphisms and serum IL-12 levels with high-risk human papillomavirus susceptibility in rural women from Luohe, Henan, China.

Authors:  Jiayu Song; Qingwei Zhang; Rong Wang; Mingzhen Sun; Shaoju Jin
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 4.  A Review of Cancer Genetics and Genomics Studies in Africa.

Authors:  Solomon O Rotimi; Oluwakemi A Rotimi; Bodour Salhia
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 5.738

5.  Associations between hepatocellular carcinoma risk and rs3212227 and rs568408 polymorphisms: a systematic review and meta-analysis.

Authors:  Cunqing Kong; Miao Chen; Xiaohui Fan; Xingcai Chen
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.